Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Public ClinicalTrials.gov record NCT01174030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 4-week, Randomized, Double-blind, Parallel-group, Vehicle-controlled, Multicenter Study Investigating the Efficacy and Safety of CD07805/47 Gel 0.5% Applied Topically Once Daily (QD), and CD07805/47 Gel 0.18% Applied Topically Once Daily (QD) or Twice Daily (BID), in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea
Study identification
- NCT ID
- NCT01174030
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 269 participants
Conditions and interventions
Conditions
Interventions
- CD07805/47 Gel Drug
- Vehicle Gel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2010
- Primary completion
- Nov 30, 2010
- Completion
- Dec 31, 2010
- Last update posted
- Feb 25, 2021
2010 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| University of California at San Francisco | San Francisco | California | 94143-0660 | — |
| Meda Phase, Inc | Newnan | Georgia | 30263 | — |
| Dermatology Specialists PC | Louisville | Kentucky | 40202 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Central Dermatology, PC | St Louis | Missouri | 63117 | — |
| Skin Specialty Group | New York | New York | 10021 | — |
| Dermatology Laser & Vein Specialists | Charlotte | North Carolina | 28207 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Oregon Dermatology & Research Center | Portland | Oregon | 97210 | — |
| Oregon Medical Research | Portland | Oregon | 97223 | — |
| Philadelphia Institute of Dermatology | Fort Washington | Pennsylvania | 19034 | — |
| DermDox | Hazleton | Pennsylvania | 18201 | — |
| Palmetto Clinical Trial Services, LLC | Greenville | South Carolina | 29007 | — |
| The Skin Wellness Center | Knoxville | Tennessee | 37902 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| The Education & Research Foundation | Lynchburg | Virginia | 24501 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
| Madison Skin & Research | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01174030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 25, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01174030 live on ClinicalTrials.gov.